Oxford Nanopore Technologies plc ONT.L Stock
Oxford Nanopore Technologies plc Price Chart
Oxford Nanopore Technologies plc ONT.L Financial and Trading Overview
Oxford Nanopore Technologies plc stock price | 107 GBP |
Previous Close | 227.4 GBP |
Open | 0 GBP |
Bid | 0 GBP x N/A |
Ask | 0 GBP x N/A |
Day's Range | 0 - 0 GBP |
52 Week Range | 0 - 341.5 GBP |
Volume | 15.6M GBP |
Avg. Volume | 1.35M GBP |
Market Cap | 2.08B GBP |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.15 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 347.9 GBP |
ONT.L Valuation Measures
Enterprise Value | 1.55B GBP |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 10.469016 |
Price/Book (mrq) | 266.4286 |
Enterprise Value/Revenue | 7.828 |
Enterprise Value/EBITDA | -18.853 |
Trading Information
Oxford Nanopore Technologies plc Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -30.030% |
S&P500 52-Week Change | 20.43% |
52 Week High | 341.5 GBP |
52 Week Low | 0 GBP |
50-Day Moving Average | 237.82 GBP |
200-Day Moving Average | 246.6 GBP |
ONT.L Share Statistics
Avg. Volume (3 month) | 1.35M GBP |
Avg. Daily Volume (10-Days) | 2.02M GBP |
Shares Outstanding | 827.5M |
Float | 516.24M |
Short Ratio | N/A |
% Held by Insiders | 34.19% |
% Held by Institutions | 41.09% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -45.83% |
Operating Margin (ttm) | -49.58% |
Gross Margin | 62.33% |
EBITDA Margin | -41.52% |
Management Effectiveness
Return on Assets (ttm) | -7.38% |
Return on Equity (ttm) | -13.026% |
Income Statement
Revenue (ttm) | 198.6M GBP |
Revenue Per Share (ttm) | 0.24 GBP |
Quarterly Revenue Growth (yoy) | 2.10% |
Gross Profit (ttm) | 123.81M GBP |
EBITDA | -82461000 GBP |
Net Income Avi to Common (ttm) | -91025000 GBP |
Diluted EPS (ttm) | -0.1 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 356.78M GBP |
Total Cash Per Share (mrq) | 0.43 GBP |
Total Debt (mrq) | 34.1M GBP |
Total Debt/Equity (mrq) | 4.92 GBP |
Current Ratio (mrq) | 6.222 |
Book Value Per Share (mrq) | 0.84 |
Cash Flow Statement
Operating Cash Flow (ttm) | -49387000 GBP |
Levered Free Cash Flow (ttm) | -36325876 GBP |
Profile of Oxford Nanopore Technologies plc
Country | United Kingdom |
State | N/A |
City | Oxford |
Address | Gosling Building |
ZIP | OX4 4DQ |
Phone | 44 84 5034 7900 |
Website | https://nanoporetech.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1009 |
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Q&A For Oxford Nanopore Technologies plc Stock
What is a current ONT.L stock price?
Oxford Nanopore Technologies plc ONT.L stock price today per share is 107 GBP.
How to purchase Oxford Nanopore Technologies plc stock?
You can buy ONT.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oxford Nanopore Technologies plc?
The stock symbol or ticker of Oxford Nanopore Technologies plc is ONT.L.
Which industry does the Oxford Nanopore Technologies plc company belong to?
The Oxford Nanopore Technologies plc industry is Biotechnology.
How many shares does Oxford Nanopore Technologies plc have in circulation?
The max supply of Oxford Nanopore Technologies plc shares is 8.6M.
What is Oxford Nanopore Technologies plc Price to Earnings Ratio (PE Ratio)?
Oxford Nanopore Technologies plc PE Ratio is now.
What was Oxford Nanopore Technologies plc earnings per share over the trailing 12 months (TTM)?
Oxford Nanopore Technologies plc EPS is -0.15 GBP over the trailing 12 months.
Which sector does the Oxford Nanopore Technologies plc company belong to?
The Oxford Nanopore Technologies plc sector is Healthcare.